Forecast & Rating14 analysts currently cover MapLight Therapeutics, with about 85.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $26.69, about 138.1% upside from the current price of $11.21. Price targets range from $13.00 to $45.00 — a wide spread, showing clear disagreement over just how much MapLight Therapeutics can rise. For you, this means most professionals who study MapLight Therapeutics closely still see room for the stock to rise. Data as of Aug 17, 2026; for reference only and not investment advice.
Aug 17, 2026Price forecast
$26.69138.11%
Forecast & RatingStrong buy
14analysts
- Strong buy78.57%
- Buy7.14%
- Hold14.29%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 20, 2026
Forecast met89.2%
Stock price$11.21
Avg. target$31.0
High target$34
Low target$28
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.